Patent ID: 8642602

Claim:
A method of treating or inhibiting fibrogenesis, or treating a fibrotic disease or a secondary disease state or condition thereof comprising administering to a patient in need thereof a compound according to the chemical structure Where R 1 is H, an acyl group, a C 1 -C 20 alkyl or ether group, an amino acid group (D or L), a phosphate, diphosphate, triphosphate or phosphodiester group; R 2 is H, an acyl group, a C 1 -C 20 alkyl or ether group or an amino acid group (D or L); and D is H, F, Cl or Br, or a pharmaceutically acceptable salt thereof, wherein said fibrotic disease is liver fibrosis, renal fibrosis, lung fibrosis, hypersensitivity pneumonitis, interstitial fibrosis, systemic scleroderma, macular degeneration, pancreatic fibrosis, fibrosis of the spleen, cardiac fibrosis, mediastinal fibrosis, myelofibrosis, endomyocardial fibrosis, retroperitoneal fibrosis, progressive massive fibrosis, nephrogenic systemic fibrosis, fibrotic complications of surgery or injection fibrosis and said secondary disease state or condition is cirrhosis, diffuse parenchymal lung disease, post-vasectomy pain syndrome or rheumatoid arthritis.